|
Match
|
Document |
Document Title |
|
|
4743585 |
Renin inhibitors
The invention concerns novel renin-inhibitory peptides which are useful for treating renin associated hypertension and for treating hyperaldosteronism. Novel intermediates, processes for preparing...
|
|
|
4737364 |
Nutritional dry food concentrate
A highly nutritional dry food concentrate consisting entirely of plant and other non-animal natural components having a low caloric content and containing no added simple sugars. The nutritional...
|
|
|
4721618 |
Method for controlling bleeding
Factor VIII:C deficiency in a hemophilic mammal may be bypassed by infusion of a synergistic mixture of a phospholipid and Factor Xa so that the cascade process of blood clotting may continue. The...
|
|
|
4721706 |
Controlling grain insects with phosphatides
Insect infestation of grain is controlled by contacting the grain, or a locus separating the grain from an insect population, with an insecticidally effective amount of a liquid comprising a...
|
|
|
4719111 |
Novel composition for treatment of decubitus ulcers
A composition for treatment of decubitus ulcers comprising an admixture of from about 10 to about 50 parts lecithin, from about 10 to about 50 parts goldenseal root or rhizome, and from about 10 to...
|
|
|
4713376 |
Dementia-improving and therapeutic agents
An improving and therapeutic agent for neuropsychiatric symptoms accompanying dementia, which comprises, as an active ingredient, an acyloxyalkanoylcholine salt represented by the following general...
|
|
|
4698362 |
Low viscosity oil based pesticide compositions
The present disclosure is concerned with a technique for producing storage stable, non-caking, low viscosity pesticidal concentrates and the compositions so obtained. The technique involves milling...
|
|
|
4687762 |
Water soluble drug complex and method for production of same
The invention provides a method of producing a water-soluble complex comprising a water-insoluble drug and a phospholipid, comprising the steps of (1) dissolving a water-insoluble drug and a...
|
|
|
4687766 |
Pharmaceutical preparation for the therapeutic treatment of rheumatic diseases
Pharmaceutical preparation containing phospholipids for the therapeutic treatment of rheumatic diseases which contain in addition to the antiphlogistically acting oxicam derivatives of the general...
|
|
|
4684633 |
Phospholipid-emulsified prostaglandin composition
A prostaglandin emulsion composition comprising a prostaglandin emulsified with a phosphatidylethanolamine-free phospholipid, the composition being suitable for intravenous administration.
|
|
|
4684520 |
Pharmaceutical compositions having cerebral antianoxic and metabolic activities
The invention relates to novel pharmaceutical compositions containing ubiquinone, particularly Coenzyme Q 10 , and mixtures of phospholipids having organic or vegetal origin, in weight-ratios...
|
|
|
4684632 |
Formulation with special 1,2-diacylglycero-3-phosphocholines for the treatment of gastrointestinal disorders
Pharmaceutical formulations for the treatment of gastrointestinal disorders, which contain as the active component an effective gastrointestinal disorder alleviating amount of a...
|
|
|
4678808 |
Rapid acting intravenous emulsions of omega-3 fatty acid esters
Described are lipid emulsions of marine oils comprising high concentrations of omega-3-fatty acid esters and low concentrations of free fatty acids for intraveneous administration for the treatment...
|
|
|
4677099 |
Medical processes employing a novel lipid fraction
The invention concerns novel lipid extracts obtainable from natural sources such as egg, yolk or soyabean; and useful for treating various diseases and physiologic conditions.
|
|
|
4675310 |
Liposome composition as gas transport agents
The invention herein involves the use of ligands and phospholipid liposomes as a carrier for the transport of various gases.
|
|
|
4666893 |
Methods of inducing resistance to bacterial and viral infections
A variety of substances are known which promote host resistance to bacterial and viral infections. Lowever, because of the unpredictable vagaries of such organisms, there is seemingly a never...
|
|
|
4665069 |
Analgesic composition and method of relieving pain
An analgesia composition comprising an aqueous solution of a neurologically active agent in a concentration of from about 10 -3 to about 10 -13 grams/ml and a method of relieving pain comprising...
|
|
|
4647586 |
Pharmaceutical oil-in-water type micro-emulsion
A pharmaceutical oil-in-water type micro-emulsion comprising fine particles of an oil or fat containing an effective amount of a 4-biphenylylacetic acid ester of the formula ##STR1## wherein R...
|
|
|
4636494 |
Process and composition for treating disorders by administering amphetamine and choline
Choline or a natural or synthetic compound that dissociates to form choline is administered to a patient concomitantly with a drug in order to potentiate the effect of the drug by increasing...
|
|
|
4626527 |
Process for utilizing choline to sustain muscular performance
Choline or a natural or synthetic compound that dissociates to form choline is administered to a patient who has or is about to participate in major exercise in order to decrease fatigue by...
|
|
|
4610880 |
Composition for controlling hemophilia in mammals
A composition of matter for controlling Hemophilia A (Antihemophilic Factor (F. VIII:C) deficiency) in mammals is described. Factor VIII:C deficiency in the mammal is bypassed by infusion of a...
|
|
|
4609647 |
Cytidyl diphosphocholine-drug composition and process
Cytidyl diphosphocholine is administered to a patient alone to increase brain acetylcholine levels or concomitantly with a drug in order to potentiate the effect of the drug by increasing...
|
|
|
4603124 |
Surfactant and pharmaceutical compositions containing same
A surfactant having the capacity of reducing the surface tension in pulmonary alveoli significantly is provided. The surfactant consists essentially of, based on the total weight of the surfactant,...
|
|
|
4600708 |
Propranolol hydrochloride liquid formulations
Therapeutic liquid oral dosage formulations of propranolol hydrochloride are provided which contain lecithin and/or a basic amino acid to impart taste masking characteristics and/or contain a basic...
|
|
|
4596788 |
Gelatin and lecithin based synthetic whole blood and a method of making the same
A composition of matter which comprises a synthetic whole blood useful as a replacement for whole mammalian blood and a method of making the same are disclosed. The method of manufacture makes use...
|
|
|
4582824 |
Method for inhibiting activities of platelet activating factor
Compounds of the formula ##STR1## wherein R 1 is a C 10 -24 alkyl group, R 2 is a C 1 -4 alkyl group or a phenyl-C 1 -3 alkyl group and A + is a heterocyclic group containing a quaternized...
|
|
|
4569929 |
Cytidyl diphosphocholine-drug composition
Cytidyl diphosphocholine is administered to a patient alone to increase brain acetylcholine levels or concomitantly with a drug in order to potentiate the effect of the drug by increasing...
|
|
|
4567045 |
Isotonic glycerol free intravenous fat emulsion
Sterile, glycerol free lipid emulsion suitable for parenteral administration and including alanine in an amount sufficient to provide pharmaceutically acceptable osmolality.
|
|
|
4567161 |
Liquid active ingredient concentrates for preparation of microemulsions
Liquid, active substance formulations containing an active substance insoluble or poorly soluble in water, or a mixture, a phospholipid, a special co-emulsifier (glycerinester in which the 1 or 2...
|
|
|
4565696 |
Production of immunogens by antigen conjugation to liposomes
Enhanced immunogenicity is achieved by covalently linking immunogens to liposomes and injecting the membrane-bound-proteins into an appropriate vertebrate host. Methods and compositions are...
|
|
|
4547490 |
Synthetic whole blood and a method of making the same
A composition of matter which comprises a synthetic whole blood useful as a substitute for whole natural blood and a method of making the same are disclosed. The method of manufacture yields a...
|
|
|
4537782 |
Emulsifying system based on a fatty acid or a protein condensate, a polyoxyethylenated sterol and a phosphatide, and a cosmetic or pharmaceutical composition containing the same
An emulsifying system for use in the production of cosmetic or pharmaceutical compositions in the form of an emulsoid or gel comprises (i) at least one fatty acid having from 8 to 22 carbon atoms...
|
|
|
4528193 |
Inflammation-preventing pharmaceutical composition of oral administration
A novel pharmaceutical composition is provided which is suitable for the prevention of inflammation and which comprises a non-steroidal inflammation-preventing compound (e.g. pyrazolones,...
|
|
|
4508703 |
Production of pulverulent mixtures of lipidic and hydrophobic constituents
The invention relates to a method for preparing a pulverulent mixture of amphiphilic lipidic constituents and possibly of hydrophobic constituents, as well as to a method for producing hydrated...
|
|
|
4486448 |
Copper lanolate and anti-acne compositions containing the same for topical application to the skin
Copper lanolate, a novel product, can be produced by initially preparing an isotropic solution of a sodium or potassium salt of lanolic acid and thereafter precipitating copper lanolate therefrom...
|
|
|
4474773 |
Lipid fraction for treating disease
The invention concerns novel lipid extracts obtainable from natural sources such as egg, yolk or soyabean; and useful for treating various diseases and physiologic conditions.
|
|
|
4473563 |
Lipid vesicles containing inositol hexaphosphate
The invention provides erythrocytes of improved O 2 -release properties having fused thereto small allosteric effectors, f.i. inositol hexaphosphate-containing lipid vesicles. Also included in the...
|
|
|
4421748 |
Artificial tear aid
An artificial tear composition comprising a sterile, aqueous hypotonic solution of lecithin and a viscosity-adjusting agent.
|
|
|
4411894 |
Pharmaceutical preparations
Pharmaceutical compositions useful for the parenteral administration of fat-soluble medicaments are disclosed. The compositions comprise, in addition to the medicaments, a sugar-containing liposome...
|
|
|
4396612 |
Use of phospholipids as mould inhibiting agents in siloed forage
Compositions containing as their main ingredient phospholipids of vegetable origin, preferably from soybean oil, are used by dispersing in water and spraying on to siloed forage to prevent mould...
|
|
|
4385053 |
Treatment for human memory impairment associated with aging
A process is disclosed for treating human memory impairment associated with aging, such as occurs in Alzheimer's disease, by administering a central nervous system cholinergic precursor such as...
|
|
|
4377567 |
Lipid membrane drug delivery
Lipid Membrane Structures comprising Digalactosyl Diglyceride target the liver of humans and lower animals and are used to carry drugs to that organ, preferentially. Digalactosyl Diglyceride LMS...
|
|
|
4372949 |
Treatment of cancer with carcinostatic and immunostimulating agent containing lysophospholipid and phospholipid
A carcinostatic and immunostimulating agent containing a lysophospholipid and a phospholipid. Said carcinostatic and immunostimulating agent is useful for the treatment of cancerous diseases of the...
|
|
|
4358442 |
Rosmarinic acid-phospholipide-complex
The present invention is directed to a new rosmarinic acid-phospholipide-complex product containing rosmarinic acid and the phospholipide in a molar ratio of 1:2. The invention is further directed...
|
|
|
4331654 |
Magnetically-localizable, biodegradable lipid microspheres
Drug carrier formulation consisting of magnetically-localizable, biodegradable lipid microspheres.
|
|
|
4323563 |
Fat emulsion for intravenous injection
A pharmaceutically acceptable emulsifier for preparing fat emulsions for intravenous injection comprising purified phospholipid of vegetable origin, containing less than 5% of glycolipid, and...
|
|
|
4321259 |
Controlled improvement of the O.sub.2 -release by intact erythrocytes
The invention provides erythrocytes of improved O 2 -release properties having fused thereto small allosteric effectors, f.i. inositol hexaphosphate-containing lipid vesicles. Also included in the...
|
|
|
4309421 |
Stabilized parenterally administrable solutions
Solutions of anti-inflammatory acrylacetic and arylpropionic acid derivatives are stabilized by addition of phospholipids. The solutions are suitable for parenteral administration; they are well...
|
|
|
4280996 |
Fat emulsion for intravenous injection
A stable fat emulsion having low side effects, which is suitable as nutritive infusion fluid for intravenous injection, is provided. The emulsion contains 5-50 (W/V) % of soybean oil, yolk...
|
|
|
4263286 |
Therapeutic agent for consciousness disorder and perception and movement disorder
A therapeutic agent for treating consciousness disorder and perception and movement which comprises as an essential active ingredient a phosphatidic acid derivative selected from a...
|